siRNA treatment reduces triglycerides in individuals with unusual condition

.ANALYSIS FEATURE.19 September 2024.

Plozasiran lowered triglyceride degrees by 80% and lowered the danger of pancreatitis in clients with persistent chylomicronemia, along with or without a genetic prognosis.